{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:21:37Z","timestamp":1792167697461,"version":"4.4.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Membrane Biol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00232-014-9637-0","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T10:22:33Z","timestamp":1393410153000},"page":"291-307","source":"Crossref","is-referenced-by-count":279,"title":["Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy"],"prefix":"10.1007","volume":"247","author":[{"given":"Stephanie","family":"Tortorella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"issue":"6","key":"9637_CR1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0021-9258(19)62337-9","volume":"253","author":"P Aisen","year":"1978","unstructured":"Aisen P, Leibman A, Zweier J (1978) Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem 253(6):1930\u20131937","journal-title":"J Biol Chem"},{"issue":"21","key":"9637_CR2","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1073\/pnas.86.21.8545","volume":"86","author":"JK Batra","year":"1989","unstructured":"Batra JK, Jinno Y, Chaudhary VK, Kondo T, Willingham MC, FitzGerald DJ, Pastan I (1989) Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proc Natl Acad Sci USA 86(21):8545\u20138549","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9637_CR3","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/MCB.11.4.2200","volume":"11","author":"JK Batra","year":"1991","unstructured":"Batra JK, Fitzgerald DJ, Chaudhary VK, Pastan I (1991) Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv). Mol Cell Biol 11(4):2200\u20132205","journal-title":"Mol Cell Biol"},{"issue":"6","key":"9637_CR4","first-page":"2211","volume":"11","author":"N Bejaoui","year":"1991","unstructured":"Bejaoui N, Page M, Noel C (1991) Cytotoxicity of transferrin\u2013daunorubicin conjugates on small cell carcinoma of the lung (SCCL) cell line NCI-H69. Anticancer Res 11(6):2211\u20132213","journal-title":"Anticancer Res"},{"issue":"1","key":"9637_CR5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/abbi.1993.1048","volume":"300","author":"A Berczi","year":"1993","unstructured":"Berczi A, Barabas K, Sizensky JA, Faulk WP (1993) Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells. Arch Biochem Biophys 300(1):356\u2013363","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"9637_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.1988.tb04218.x","volume":"68","author":"G Bergamaschi","year":"1988","unstructured":"Bergamaschi G, Cazzola M, Dezza L, Savino E, Consonni L, Lappi D (1988) Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6). Br J Haematol 68(3):379\u2013384","journal-title":"Br J Haematol"},{"issue":"3","key":"9637_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/j.1460-2075.1982.tb01173.x","volume":"1","author":"JD Bleil","year":"1982","unstructured":"Bleil JD, Bretscher MS (1982) Transferrin receptor and its recycling in HeLa cells. EMBO J 1(3):351\u2013355","journal-title":"EMBO J"},{"issue":"2","key":"9637_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biotechadv.2010.11.007","volume":"29","author":"M Brandsma","year":"2011","unstructured":"Brandsma M, Jevnikar A, Ma S (2011) Recombinant human transferrin: beyond iron binding and transport. Biotechnol Adv 29(2):230\u2013238","journal-title":"Biotechnol Adv"},{"issue":"21","key":"9637_CR9","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.1016\/S0021-9258(18)90642-3","volume":"259","author":"KR Bridges","year":"1984","unstructured":"Bridges KR, Cudkowicz A (1984) Effect of iron chelators on the transferrin receptor in K562 cells. J Biol Chem 259(21):12970\u201312977","journal-title":"J Biol Chem"},{"issue":"5","key":"9637_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0169-409X(02)00044-3","volume":"54","author":"I Brigger","year":"2002","unstructured":"Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54(5):631\u2013651","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"9637_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0306-4522(03)00590-6","volume":"121","author":"JR Burdo","year":"2003","unstructured":"Burdo JR, Antonetti DA, Wolpert EB, Connor JR (2003) Mechanisms and regulation of transferrin and iron transport in a model blood\u2013brain barrier system. Neuroscience 121(4):883\u2013890","journal-title":"Neuroscience"},{"issue":"3","key":"9637_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/BJ20040230","volume":"381","author":"A Calzolari","year":"2004","unstructured":"Calzolari A, Deaglio S, Sposi N, Petrucci E, Morsilli O, Gabbianelli M, Malavasi F, Peschle C, Testa U (2004) Transferrin receptor 2 protein is not expressed in normal erythroid cells. Biochem J 381(3):629\u2013634","journal-title":"Biochem J"},{"issue":"1","key":"9637_CR13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcmd.2007.02.003","volume":"39","author":"A Calzolari","year":"2007","unstructured":"Calzolari A, Oliviero I, Deaglio S, Mariani G, Biffoni M, Sposi N, Malavasi F, Peschle C, Testa U (2007) Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis 39(1):82\u201391","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"9637_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1593\/tlo.09274","volume":"3","author":"A Calzolari","year":"2010","unstructured":"Calzolari A, Larocca L, Deaglio S, Finisguerra V, Boe A, Raggi C, Ricci Vitani L, Pierconti F, Malavasi F, De Maria R, Testa U, Pallini R (2010) Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol 3(2):123\u2013134","journal-title":"Transl Oncol"},{"key":"9637_CR15","author":"FS Carvalho","year":"2013","unstructured":"Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ (2013) Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. doi: 10.1002\/med.21280","journal-title":"Med Res Rev"},{"issue":"6","key":"9637_CR16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s11095-011-0624-1","volume":"29","author":"J Chang","year":"2012","unstructured":"Chang J, Paillard A, Passirani C, Morille M, Benoit J-P, Betbeder D, Garcion E (2012) Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res 29(6):1495\u20131505","journal-title":"Pharm Res"},{"issue":"2","key":"9637_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2006.02.011","volume":"112","author":"S-J Chiu","year":"2006","unstructured":"Chiu S-J, Liu S, Perrotti D, Marcucci G, Lee R (2006) Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release 112(2):199\u2013207","journal-title":"J Control Release"},{"issue":"11\u201312","key":"9637_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2011.04.003","volume":"16","author":"S Choudhary","year":"2011","unstructured":"Choudhary S, Mathew M, Verma RS (2011) Therapeutic potential of anticancer immunotoxins. Drug Discov Today 16(11\u201312):495\u2013503","journal-title":"Drug Discov Today"},{"issue":"16","key":"9637_CR19","doi-asserted-by":"crossref","first-page":"9681","DOI":"10.1016\/S0021-9258(17)44551-0","volume":"258","author":"A Ciechanover","year":"1983","unstructured":"Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF (1983) Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem 258(16):9681\u20139689","journal-title":"J Biol Chem"},{"issue":"3","key":"9637_CR20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jcp.22805","volume":"227","author":"A Cimini","year":"2012","unstructured":"Cimini A, Mei S, Benedetti E, Laurenti G, Koutris I, Cinque B, Cifone MG, Galzio R, Pitari G, Di Leandro L, Giansanti F, Lombardi A, Fabbrini MS, Ippoliti R (2012) Distinct cellular responses induced by saporin and a transferrin\u2013saporin conjugate in two different human glioblastoma cell lines. J Cell Physiol 227(3):939\u2013951","journal-title":"J Cell Physiol"},{"issue":"6927","key":"9637_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","volume":"422","author":"S Conner","year":"2003","unstructured":"Conner S, Schmid S (2003) Regulated portals of entry into the cell. Nature 422(6927):37\u201344","journal-title":"Nature"},{"issue":"2","key":"9637_CR22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","volume":"121","author":"T Daniels","year":"2006","unstructured":"Daniels T, Delgado T, Rodriguez J, Helguera G, Penichet M (2006a) The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121(2):144\u2013158","journal-title":"Clin Immunol"},{"issue":"2","key":"9637_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels TR, Delgado T, Helguera G, Penichet ML (2006b) The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clinical Immunology 121(2):159\u2013176. doi: 10.1016\/j.clim.2006.06.006","journal-title":"Clinical Immunology"},{"issue":"11","key":"9637_CR24","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1158\/1535-7163.MCT-07-0330","volume":"6","author":"TR Daniels","year":"2007","unstructured":"Daniels TR, Ng PP, Delgado T, Lynch MR, Schiller G, Helguera G, Penichet ML (2007) Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol Cancer Ther 6(11):2995\u20133008","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"9637_CR25","first-page":"37","volume":"4","author":"A Das Gupta","year":"1990","unstructured":"Das Gupta A, Shah VI (1990) Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and Non-Hodgkin\u2019s lymphoma. Hematol Pathol 4(1):37\u201341","journal-title":"Hematol Pathol"},{"issue":"8","key":"9637_CR26","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.80.8.2258","volume":"80","author":"A Dautry Varsat","year":"1983","unstructured":"Dautry Varsat A, Ciechanover A, Lodish HF (1983) pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80(8):2258\u20132262","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"9637_CR27","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1182\/blood-2002-01-0076","volume":"100","author":"S Deaglio","year":"2002","unstructured":"Deaglio S, Capobianco A, Cal\u0131 A, Bellora F, Alberti F, Righi L, Sapino A, Camaschella C, Malavasi F (2002) Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. Blood 100(10):3782\u20133789. doi: 10.1182\/blood-2002-01-0076","journal-title":"Blood"},{"issue":"4","key":"9637_CR28","first-page":"H1149","volume":"270","author":"L Descamps","year":"1996","unstructured":"Descamps L, Dehouck MP, Torpier G, Cecchelli R (1996) Receptor-mediated transcytosis of transferrin through blood\u2013brain barrier endothelial cells. Am J Physiol 270(4):H1149\u2013H1158","journal-title":"Am J Physiol"},{"issue":"5","key":"9637_CR29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4155\/tde.13.21","volume":"4","author":"C Dufes","year":"2013","unstructured":"Dufes C, Al Robaian M, Somani S (2013) Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Therapeutic delivery 4(5):629\u2013640","journal-title":"Therapeutic delivery"},{"key":"9637_CR30","first-page":"334","volume":"3","author":"J-M Hage Chahine El","year":"1820","unstructured":"El Hage Chahine J-M, H\u00e9madi M, Ha-Duong N-T (1820) H\u00e9madi M, Ha-Duong NT (2012) Uptake and release of metal ions by transferrin and interaction with receptor 1. Biochimica et Biophysica Acta (BBA) 3:334\u2013347. doi: 10.1016\/j.bbagen.2011.07.008 General Subjects","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"9637_CR31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/cbr.2006.21.138","volume":"21","author":"R Elliott","year":"2006","unstructured":"Elliott R, Head J (2006) Complete resolution of malignant ascites in stage IV breast cancer by peritoneal drainage and innovative chemoimmunotherapy: a case report. Cancer Biother Radiopharm 21(2):138\u2013145","journal-title":"Cancer Biother Radiopharm"},{"issue":"8191","key":"9637_CR32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(80)90440-7","volume":"2","author":"WP Faulk","year":"1980","unstructured":"Faulk WP, Hsi BL, Stevens PJ (1980) Transferrin and transferrin receptors in carcinoma of the breast. Lancet (Lond) 2(8191):390\u2013392","journal-title":"Lancet (Lond)"},{"issue":"1","key":"9637_CR33","first-page":"57","volume":"2","author":"WP Faulk","year":"1990","unstructured":"Faulk WP, Taylor CG, Yeh CJ, McIntyre JA (1990) Preliminary clinical study of transferrin\u2013adriamycin conjugate for drug delivery to acute leukemia patients. Mol Biother 2(1):57\u201360","journal-title":"Mol Biother"},{"issue":"5","key":"9637_CR34","first-page":"815","volume":"25","author":"WP Faulk","year":"1991","unstructured":"Faulk WP, Barabas K, Sun IL, Crane FL (1991) Transferrin\u2013adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells. Biochem Int 25(5):815\u2013822","journal-title":"Biochem Int"},{"issue":"2","key":"9637_CR35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","volume":"333","author":"N Ferrara","year":"2005","unstructured":"Ferrara N, Hillan KJ, Novotny W (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333(2):328\u2013335. doi: 10.1016\/j.bbrc.2005.05.132","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"9637_CR36","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","volume":"88","author":"PM Friden","year":"1991","unstructured":"Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM (1991) Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood\u2013brain barrier. Proc Natl Acad Sci USA 88(11):4771\u20134775","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9637_CR37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood.V55.2.240.240","volume":"55","author":"GM Galbraith","year":"1980","unstructured":"Galbraith GM, Galbraith RM, Temple A, Faulk WP (1980) Demonstration of transferrin receptors on human placental trophoblast. Blood 55(2):240\u2013242","journal-title":"Blood"},{"issue":"5","key":"9637_CR38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.36.5.539","volume":"36","author":"KC Gatter","year":"1983","unstructured":"Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY (1983) Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 36(5):539\u2013545","journal-title":"J Clin Pathol"},{"issue":"1","key":"9637_CR39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48\u201358","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"9637_CR40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002371-199201000-00002","volume":"11","author":"TW Griffin","year":"1992","unstructured":"Griffin TW, Stocl M, Collins J, Fernandes J, Maher VE (1992) Combined antitumor therapy with the chemotherapeutic drug doxorubicin and an anti-transferrin receptor immunotoxin: in vitro and in vivo studies. J Immunother 11(1):12\u201318","journal-title":"J Immunother"},{"issue":"8323","key":"9637_CR41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(83)92191-8","volume":"1","author":"JA Habeshaw","year":"1983","unstructured":"Habeshaw JA, Lister TA, Stansfeld AG, Greaves MF (1983) Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet (Lond) 1(8323):498\u2013501","journal-title":"Lancet (Lond)"},{"issue":"12","key":"9637_CR42","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1073\/pnas.76.12.6406","volume":"76","author":"TA Hamilton","year":"1979","unstructured":"Hamilton TA, Wada HG, Sussman HH (1979) Identification of transferrin receptors on the surface of human cultured cells. Proceedings of the National Academy of Sciences of the United States of America. Proc Natl Acad Sci USA 76(12):6406\u20136410","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9637_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-3083.1982.tb00735.x","volume":"16","author":"ML Hammarstr\u00f6m","year":"1982","unstructured":"Hammarstr\u00f6m ML, Axelsson B, Ivansen M, Hammarstr\u00f6m S, Perlmann P (1982) Transferrin receptors on mitogen-stimulated human thymus-derived lymphocytes. Scand J Immunol 16(4):355\u2013360","journal-title":"Scand J Immunol"},{"key":"9637_CR44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0065-2571(96)00010-6","volume":"37","author":"JF Head","year":"1997","unstructured":"Head JF, Wang F, Elliott RL (1997) Antineoplastic drugs that interfere with iron metabolism in cancer cells. Adv Enzyme Regul 37:147\u2013169","journal-title":"Adv Enzyme Regul"},{"issue":"5","key":"9637_CR45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23(5):1011\u20131027. doi: 10.1200\/jco.2005.06.081","journal-title":"J Clin Oncol"},{"issue":"2","key":"9637_CR46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1083\/jcb.97.2.508","volume":"97","author":"CR Hopkins","year":"1983","unstructured":"Hopkins CR, Trowbridge IS (1983) Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J Cell Biol 97(2):508\u2013521","journal-title":"J Cell Biol"},{"issue":"2","key":"9637_CR47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jps.2600840219","volume":"84","author":"T Hoshino","year":"1995","unstructured":"Hoshino T, Misaki M, Yamamoto M, Shimizu H, Ogawa Y, Toguchi H (1995) In vitro cytotoxicities and in vivo distribution of transferrin\u2013platinum(II) complex. J Pharm Sci 84(2):216\u2013221","journal-title":"J Pharm Sci"},{"issue":"29","key":"9637_CR48","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1016\/j.biomaterials.2013.04.067","volume":"34","author":"Y Huang","year":"2013","unstructured":"Huang Y, He L, Liu W, Fan C, Zheng W, Wong Y-S, Chen T (2013) Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials 34(29):7106\u20137116. doi: 10.1016\/j.biomaterials.2013.04.067","journal-title":"Biomaterials"},{"issue":"2","key":"9637_CR49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1152\/physrev.1987.67.2.520","volume":"67","author":"HA Huebers","year":"1987","unstructured":"Huebers HA, Finch CA (1987) The physiology of transferrin and transferrin receptors. Physiol Rev 67(2):520\u2013582","journal-title":"Physiol Rev"},{"issue":"12","key":"9637_CR50","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1096\/fasebj.9.12.7672515","volume":"9","author":"R Ippoliti","year":"1995","unstructured":"Ippoliti R, Lendaro E, D\u2019Agostino I, Fiani ML, Guidarini D, Vestri S, Benedetti PA, Brunori M (1995) A chimeric saporin\u2013transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity. FASEB J 9(12):1220\u20131225","journal-title":"FASEB J"},{"issue":"1\u20133","key":"9637_CR51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(00)00131-9","volume":"46","author":"RK Jain","year":"2001","unstructured":"Jain RK (2001) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46(1\u20133):149\u2013168","journal-title":"Adv Drug Deliv Rev"},{"issue":"5990","key":"9637_CR52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","volume":"312","author":"WA Jefferies","year":"1984","unstructured":"Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312(5990):162\u2013163","journal-title":"Nature"},{"issue":"1","key":"9637_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/bc060135f","volume":"18","author":"YY Jiang","year":"2007","unstructured":"Jiang YY, Liu C, Hong MH, Zhu SJ, Pei YY (2007) Tumor cell targeting of transferrin\u2013PEG\u2013TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation. Bioconjug Chem 18(1):41\u201349","journal-title":"Bioconjug Chem"},{"key":"9637_CR54","doi-asserted-by":"crossref","unstructured":"Jiang W, KimBetty YS, Rutka JT, ChanWarren CW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nano 3(3):145\u2013150. http:\/\/www.nature.com\/nnano\/journal\/v3\/n3\/suppinfo\/nnano.2008.30_S1.html","DOI":"10.1038\/nnano.2008.30"},{"issue":"24","key":"9637_CR55","doi-asserted-by":"crossref","first-page":"18390","DOI":"10.1016\/S0021-9258(17)46856-6","volume":"268","author":"M Jin","year":"1993","unstructured":"Jin M, Snider MD (1993) Role of microtubules in transferrin receptor transport from the cell surface to endosomes and the Golgi complex. J Biol Chem 268(24):18390\u201318397","journal-title":"J Biol Chem"},{"issue":"3","key":"9637_CR56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jphotobiol.2005.12.013","volume":"83","author":"T Karagiannis","year":"2006","unstructured":"Karagiannis T, Lobachevsky P, Martin R (2006a) DNA targeted UVA photosensitization: characterization of an extremely photopotent iodinated minor groove binding DNA ligand. J Photochem Photobiol B 83(3):195\u2013204","journal-title":"J Photochem Photobiol B"},{"issue":"21","key":"9637_CR57","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1158\/0008-5472.CAN-06-1853","volume":"66","author":"TC Karagiannis","year":"2006","unstructured":"Karagiannis TC, Lobachevsky PN, Leung BK, White JM, Martin RF (2006b) Receptor-mediated DNA-targeted photoimmunotherapy. Cancer Res 66(21):10548\u201310552","journal-title":"Cancer Res"},{"issue":"22","key":"9637_CR58","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1074\/jbc.M908846199","volume":"275","author":"H Kawabata","year":"2000","unstructured":"Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP (2000) Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 275(22):16618\u201316625","journal-title":"J Biol Chem"},{"issue":"6785","key":"9637_CR59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","volume":"405","author":"S Kersten","year":"2000","unstructured":"Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405(6785):421\u2013424","journal-title":"Nature"},{"issue":"2","key":"9637_CR60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2012.07.021","volume":"162","author":"TH Kim","year":"2012","unstructured":"Kim TH, Jo YG, Jiang HH, Lim SM, Youn YS, Lee S, Chen X, Byun Y, Lee KC (2012) PEG\u2013transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. J Control Release 162(2):422\u2013428. doi: 10.1016\/j.jconrel.2012.07.021","journal-title":"J Control Release"},{"issue":"3","key":"9637_CR61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ar3000647","volume":"46","author":"S Kim","year":"2013","unstructured":"Kim S, Saha K, Kim C, Rotello V (2013) The role of surface functionality in determining nanoparticle cytotoxicity. Acc Chem Res 46(3):681\u2013691","journal-title":"Acc Chem Res"},{"issue":"8","key":"9637_CR62","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.80.8.2263","volume":"80","author":"RD Klausner","year":"1983","unstructured":"Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR (1983a) Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 80(8):2263\u20132266","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9637_CR63","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/S0021-9258(18)32481-5","volume":"258","author":"RD Klausner","year":"1983","unstructured":"Klausner RD, Van Renswoude J, Ashwell G, Kempf C, Schechter AN, Dean A, Bridges KR (1983b) Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem 258(8):4715\u20134724","journal-title":"J Biol Chem"},{"issue":"6","key":"9637_CR64","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1378\/chest.97.6.1367","volume":"97","author":"K Kondo","year":"1990","unstructured":"Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y, Monden Y (1990) Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97(6):1367\u20131371","journal-title":"Chest"},{"issue":"2","key":"9637_CR65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2009.11.015","volume":"143","author":"S Koppu","year":"2010","unstructured":"Koppu S, Oh YJ, Edrada-Ebel R, Blatchford DR, Tetley L, Tate RJ, Duf\u00e8s C (2010) Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J Control Release 143(2):215\u2013221. doi: 10.1016\/j.jconrel.2009.11.015","journal-title":"J Control Release"},{"issue":"3","key":"9637_CR66","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/js970246a","volume":"87","author":"F Kratz","year":"1998","unstructured":"Kratz F, Beyer U, Roth T, Tarasova N, Collery P, Lechenault F, Cazabat A, Schumacher P, Unger C, Falken U (1998) Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy. J Pharm Sci 87(3):338\u2013346","journal-title":"J Pharm Sci"},{"issue":"5","key":"9637_CR67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10611860008997908","volume":"8","author":"F Kratz","year":"2000","unstructured":"Kratz F, Roth T, Fichiner I, Schumacher P, Fiebig HH, Unger C (2000) In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model. J Drug Target 8(5):305\u2013318","journal-title":"J Drug Target"},{"issue":"8","key":"9637_CR68","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20(8):716\u2013731","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"9637_CR69","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cell.2005.12.038","volume":"124","author":"M Lakadamyali","year":"2006","unstructured":"Lakadamyali M, Rust M, Zhuang X (2006) Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124(5):997\u20131009","journal-title":"Cell"},{"issue":"3","key":"9637_CR70","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3171\/jns.1994.80.3.0520","volume":"80","author":"DW Laske","year":"1994","unstructured":"Laske DW, Ilercil O, Akbasak A, Youle RJ, Oldfield EH (1994) Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J Neurosurg 80(3):520\u2013526","journal-title":"J Neurosurg"},{"issue":"5","key":"9637_CR71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00006123-199711000-00005","volume":"41","author":"DW Laske","year":"1997","unstructured":"Laske DW, Muraszko KM, Oldfield EH, DeVroom HL, Sung C, Dedrick RL, Simon TR, Colandrea J, Copeland C, Katz D, Greenfield L, Groves ES, Houston LL, Youle RJ (1997a) Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery 41(5):1039\u20131049","journal-title":"Neurosurgery"},{"issue":"12","key":"9637_CR72","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm1297-1362","volume":"3","author":"DW Laske","year":"1997","unstructured":"Laske DW, Youle RJ, Oldfield EH (1997b) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3(12):1362\u20131368","journal-title":"Nat Med"},{"issue":"2A","key":"9637_CR73","first-page":"397","volume":"14","author":"P Lemieux","year":"1994","unstructured":"Lemieux P, Page M (1994) Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate. Anticancer Res 14(2A):397\u2013403","journal-title":"Anticancer Res"},{"issue":"9","key":"9637_CR74","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/cbr.2013.1480","volume":"28","author":"G Liu","year":"2013","unstructured":"Liu G, Mao J, Jiang Z, Sun T, Hu Y, Zhang C, Dong J, Huang Q, Lan Q (2013) Transferrin-modified doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats. Cancer Biother Radiopharma 28(9):691\u2013696","journal-title":"Cancer Biother Radiopharma"},{"issue":"1","key":"9637_CR75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2478\/s11658-008-0037-2","volume":"14","author":"D Lubgan","year":"2009","unstructured":"Lubgan D, Jozwiak Z, Grabenbauer GG, Distel LV (2009) Doxorubicin\u2013transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells. Cell Mol Biol Lett 14(1):113\u2013127","journal-title":"Cell Mol Biol Lett"},{"key":"9637_CR76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394390-3.00001-X","volume":"69","author":"A Luck","year":"2012","unstructured":"Luck A, Mason A (2012) Transferrin-mediated cellular iron delivery. Curr Top Membr 69:3\u201335","journal-title":"Curr Top Membr"},{"issue":"3","key":"9637_CR77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.mib.2012.05.006","volume":"15","author":"J Madhumathi","year":"2012","unstructured":"Madhumathi J, Verma RS (2012) Therapeutic targets and recent advances in protein immunotoxins. Curr Opin Microbiol 15(3):300\u2013309. doi: 10.1016\/j.mib.2012.05.006","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"9637_CR78","first-page":"1348","volume":"53","author":"LA Martell","year":"1993","unstructured":"Martell LA, Agrawal A, Ross DA, Muraszko KM (1993) Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 53(6):1348\u20131353","journal-title":"Cancer Res"},{"issue":"5","key":"9637_CR79","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/09553009014551061","volume":"57","author":"RF Martin","year":"1990","unstructured":"Martin RF, Murray V, D\u2019Cunha G, Pardee M, Kampouris E, Haigh A, Kelly DP, Hodgson GS (1990) Radiation sensitization by an iodine-labelled DNA ligand. Int J Radiat Biol 57(5):939\u2013946","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"9637_CR80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4161\/cl.1.4.18152","volume":"1","author":"T Matsui","year":"2011","unstructured":"Matsui T, Fukuda M (2011) Small GTPase Rab12 regulates transferrin receptor degradation: implications for a novel membrane trafficking pathway from recycling endosomes to lysosomes. Cell Logist 1(4):155\u2013158","journal-title":"Cell Logist"},{"issue":"10","key":"9637_CR81","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1600-0854.2011.01240.x","volume":"12","author":"T Matsui","year":"2011","unstructured":"Matsui T, Itoh T, Fukuda M (2011) Small GTPase Rab12 regulates constitutive degradation of transferrin receptor. Traffic 12(10):1432\u20131443","journal-title":"Traffic"},{"issue":"5","key":"9637_CR82","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0021-9258(17)43197-8","volume":"259","author":"E Mattia","year":"1984","unstructured":"Mattia E, Rao K, Shapiro DS, Sussman HH, Klausner RD (1984) Biosynthetic regulation of the human transferrin receptor by desferrioxamine in K562 cells. J Biol Chem 259(5):2689\u20132692","journal-title":"J Biol Chem"},{"issue":"3","key":"9637_CR83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2011.09.009","volume":"1820","author":"K Mayle","year":"2012","unstructured":"Mayle K, Le A, Kamei D (2012) The intracellular trafficking pathway of transferrin. Biochimica et biophysica acta 1820(3):264\u2013281","journal-title":"Biochimica et biophysica acta"},{"issue":"1\u20132","key":"9637_CR84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(01)02359-6","volume":"495","author":"MW McCaffrey","year":"2001","unstructured":"McCaffrey MW, Bielli A, Cantalupo G, Mora S, Roberti V, Santillo M, Drummond F, Bucci C (2001) Rab4 affects both recycling and degradative endosomal trafficking. FEBS Lett 495(1\u20132):21\u201330. doi: 10.1016\/S0014-5793(01)02359-6","journal-title":"FEBS Lett"},{"issue":"2","key":"9637_CR85","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0092-8674(84)90004-7","volume":"39","author":"A McClelland","year":"1984","unstructured":"McClelland A, K\u00fchn LC, Ruddle FH (1984) The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence. Cell 39(2):267\u2013274","journal-title":"Cell"},{"issue":"56","key":"9637_CR86","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1038\/sj.onc.1204082","volume":"19","author":"J Mendelsohn","year":"2000","unstructured":"Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19(56):6550\u20136565","journal-title":"Oncogene"},{"issue":"4","key":"9637_CR87","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood.V62.4.821.821","volume":"62","author":"J Mendelsohn","year":"1983","unstructured":"Mendelsohn J, Trowbridge I, Castagnola J (1983) Inhibition of human lymphocyte proliferation by monoclonal antibody to transferrin receptor. Blood 62(4):821\u2013826","journal-title":"Blood"},{"issue":"7","key":"9637_CR88","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1039\/c2cs15294k","volume":"41","author":"R Mout","year":"2012","unstructured":"Mout R, Moyano D, Rana S, Rotello V (2012) Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 41(7):2539\u20132544","journal-title":"Chem Soc Rev"},{"issue":"2","key":"9637_CR89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1464-410X.1998.00736.x","volume":"82","author":"J Munns","year":"1998","unstructured":"Munns J, Yaxley J, Coomer J, Lavin MF, Gardiner RA, Watters D (1998) Evaluation of the potential of transferrin\u2013adriamycin conjugates in the treatment of bladder cancer. Br J Urol 82(2):284\u2013289","journal-title":"Br J Urol"},{"issue":"1","key":"9637_CR90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2013.09.021","volume":"457","author":"J-P Nam","year":"2013","unstructured":"Nam J-P, Park S-C, Kim T-H, Jang J-Y, Choi C, Jang M-K, Nah J-W (2013) Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Int J Pharm 457(1):124\u2013135","journal-title":"Int J Pharm"},{"issue":"5","key":"9637_CR91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/07357908609017524","volume":"4","author":"LM Neckers","year":"1986","unstructured":"Neckers LM, Trepel JB (1986) Transferrin receptor expression and the control of cell growth. Cancer Invest 4(5):461\u2013470","journal-title":"Cancer Invest"},{"issue":"2","key":"9637_CR92","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0021-9258(20)71189-0","volume":"260","author":"DO O\u2019Keefe","year":"1985","unstructured":"O\u2019Keefe DO, Draper RK (1985) Characterization of a transferrin\u2013diphtheria toxin conjugate. J Biol Chem 260(2):932\u2013937","journal-title":"J Biol Chem"},{"issue":"6","key":"9637_CR93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/icb.1987.55","volume":"65","author":"M Panaccio","year":"1987","unstructured":"Panaccio M, Zalcberg JR, Thompson CH, Leyden MJ, Sullivan JR, Lichtenstein M, McKenzie IF (1987) Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo. Immunol Cell Biol 65(6):461\u2013472","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"9637_CR94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.111.071027","volume":"80","author":"S Paris-Robidas","year":"2011","unstructured":"Paris-Robidas S, Emond V, Tremblay C, Soulet D, Calon F (2011) In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor. Mol Pharmacol 80(1):32\u201339. doi: 10.1124\/mol.111.071027","journal-title":"Mol Pharmacol"},{"issue":"2","key":"9637_CR95","first-page":"751","volume":"45","author":"R Pirker","year":"1985","unstructured":"Pirker R, FitzGerald DJP, Hamilton TC, Ozols RF, Willingham MC, Pastan I (1985) Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines. Cancer Res 45(2):751\u2013757","journal-title":"Cancer Res"},{"issue":"14","key":"9637_CR96","first-page":"3919","volume":"48","author":"R Pirker","year":"1988","unstructured":"Pirker R, FitzGerald DJP, Willingham MC, Pastan I (1988) Enhancement of the activity of immunotoxins made with either ricin a chain or pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell lines. Cancer Res 48(14):3919\u20133923","journal-title":"Cancer Res"},{"issue":"6","key":"9637_CR97","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF01600299","volume":"416","author":"R Prior","year":"1990","unstructured":"Prior R, Reifenberger G, Wechsler W (1990) Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction. Virchows Archiv 416(6):491\u2013496","journal-title":"Virchows Archiv"},{"issue":"2","key":"9637_CR98","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2005.07.001","volume":"238","author":"M Prutki","year":"2006","unstructured":"Prutki M, Poljak Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N (2006) Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 238(2):188\u2013196","journal-title":"Cancer Lett"},{"issue":"2","key":"9637_CR99","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0021-9258(17)43579-4","volume":"259","author":"V Raso","year":"1984","unstructured":"Raso V, Basala M (1984) A highly cytotoxic human transferrin\u2013ricin A chain conjugate used to select receptor-modified cells. J Biol Chem 259(2):1143\u20131149","journal-title":"J Biol Chem"},{"issue":"6","key":"9637_CR100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3171\/jns.1990.72.6.0941","volume":"72","author":"L Recht","year":"1990","unstructured":"Recht L, Torres CO, Smith TW, Raso V, Griffin TW (1990) Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg 72(6):941\u2013945. doi: 10.3171\/jns.1990.72.6.0941","journal-title":"J Neurosurg"},{"issue":"1","key":"9637_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4157(96)00014-7","volume":"1331","author":"DR Richardson","year":"1997","unstructured":"Richardson DR, Ponka P (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331(1):1\u201340","journal-title":"Biochim Biophys Acta"},{"issue":"27","key":"9637_CR102","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1016\/S0021-9258(17)38652-0","volume":"260","author":"T Rouault","year":"1985","unstructured":"Rouault T, Rao K, Harford J, Mattia E, Klausner RD (1985) Hemin, chelatable iron, and the regulation of transferrin receptor biosynthesis. J Biol Chem 260(27):14862\u201314866","journal-title":"J Biol Chem"},{"issue":"31","key":"9637_CR103","doi-asserted-by":"crossref","first-page":"21125","DOI":"10.1016\/S0021-9258(18)54829-8","volume":"266","author":"EA Rutledge","year":"1991","unstructured":"Rutledge EA, Mikoryak CA, Draper RK (1991) Turnover of the transferrin receptor is not influenced by removing most of the extracellular domain. J Biol Chem 266(31):21125\u201321130","journal-title":"J Biol Chem"},{"issue":"9","key":"9637_CR104","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ejca.2004.01.036","volume":"40","author":"E Ryschich","year":"2004","unstructured":"Ryschich E, Huszty G, Knaebel HP, Hartel M, B\u00fcchler MW, Schmidt J (2004) Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer 40(9):1418\u20131422","journal-title":"Eur J Cancer"},{"issue":"5","key":"9637_CR105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","volume":"2","author":"SK Sahoo","year":"2005","unstructured":"Sahoo SK, Labhasetwar V (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2(5):373\u2013383. doi: 10.1021\/mp050032z","journal-title":"Mol Pharm"},{"issue":"2","key":"9637_CR106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.20405","volume":"112","author":"SK Sahoo","year":"2004","unstructured":"Sahoo SK, Ma W, Labhasetwar V (2004) Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 112(2):335\u2013340. doi: 10.1002\/ijc.20405","journal-title":"Int J Cancer"},{"issue":"14","key":"9637_CR107","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1016\/S0021-9258(18)34362-X","volume":"257","author":"C Schneider","year":"1982","unstructured":"Schneider C, Sutherland R, Newman R, Greaves M (1982) Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J Biol Chem 257(14):8516\u20138522","journal-title":"J Biol Chem"},{"issue":"5987","key":"9637_CR108","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/311675b0","volume":"311","author":"C Schneider","year":"1984","unstructured":"Schneider C, Owen MJ, Banville D, Williams JG (1984) Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature 311(5987):675\u2013678","journal-title":"Nature"},{"issue":"4","key":"9637_CR109","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0006-291X(81)90691-4","volume":"100","author":"HM Schulman","year":"1981","unstructured":"Schulman HM, Wilczynska A, Ponka P (1981) Transferrin and iron uptake by human lymphoblastoid and K-562 cells. Biochem Biophys Res Commun 100(4):1523\u20131530","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"9637_CR110","first-page":"1163","volume":"79","author":"CF Scott Jr","year":"1987","unstructured":"Scott CF Jr, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD (1987) An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. J Natl Cancer Inst 79(5):1163\u20131172","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9637_CR111","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00265663","volume":"15","author":"GJ Seymour","year":"1987","unstructured":"Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA (1987) Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 15(6):341\u2013344","journal-title":"Urol Res"},{"issue":"11","key":"9637_CR112","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/toxins2112519","volume":"2","author":"A Shapira","year":"2010","unstructured":"Shapira A, Benhar I (2010) Toxin-based therapeutic approaches. Toxins 2(11):2519\u20132583","journal-title":"Toxins"},{"issue":"4","key":"9637_CR113","first-page":"643","volume":"17","author":"H Shinohara","year":"2000","unstructured":"Shinohara H, Fan D, Ozawa S, Yano S, Van Arsdell M, Viner JL, Beers R, Pastan I, Fidler IJ (2000) Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin. Int J Oncol 17(4):643\u2013651","journal-title":"Int J Oncol"},{"issue":"3","key":"9637_CR114","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V60.3.703.703","volume":"60","author":"C Sieff","year":"1982","unstructured":"Sieff C, Bicknell D, Caine G, Robinson J, Lam G, Greaves MF (1982) Changes in cell surface antigen expression during hemopoietic differentiation. Blood 60(3):703\u2013713","journal-title":"Blood"},{"issue":"6","key":"9637_CR115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138161280506230110111312","volume":"5","author":"M Singh","year":"1999","unstructured":"Singh M (1999) Transferrin As A targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 5(6):443\u2013451","journal-title":"Curr Pharm Des"},{"issue":"3A","key":"9637_CR116","first-page":"1423","volume":"18","author":"M Singh","year":"1998","unstructured":"Singh M, Atwal H, Micetich R (1998) Transferrin directed delivery of adriamycin to human cells. Anticancer Res 18(3A):1423\u20131427","journal-title":"Anticancer Res"},{"issue":"5","key":"9637_CR117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAI.0b013e318209716e","volume":"19","author":"M Singh","year":"2011","unstructured":"Singh M, Mugler K, Hailoo D, Burke S, Nemesure B, Torkko K, Shroyer K (2011) Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma. Appl Immunohistochem Mol Morphol 19(5):417\u2013423","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"9637_CR118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","volume":"15","author":"PAJ Speth","year":"1988","unstructured":"Speth PAJ, Hoesel QGCM, Haanen C (1988) Clinical pharmacokinetics of doxorubicin. Clin-Pharmacokinet 15(1):15\u201331. doi: 10.2165\/00003088-198815010-00002","journal-title":"Clin-Pharmacokinet"},{"key":"9637_CR119","first-page":"326","volume":"3","author":"A Steere","year":"1820","unstructured":"Steere A, Byrne S, Chasteen ND (1820) Mason A (2012) Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH. Biochim Biophys Acta 3:326\u2013333","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"9637_CR120","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1016\/S0021-9258(18)67527-1","volume":"261","author":"BS Stein","year":"1986","unstructured":"Stein BS, Sussman HH (1986) Demonstration of two distinct transferrin receptor recycling pathways and transferrin-independent receptor internalization in K562 cells. J Biol Chem 261(22):10319\u201310331","journal-title":"J Biol Chem"},{"issue":"1","key":"9637_CR121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0005-2736(92)90165-I","volume":"23","author":"IL Sun","year":"1992","unstructured":"Sun IL, Sun EE, Crane FL, Morre DJ, Faulk WP (1992) Inhibition of transplasma membrane electron transport by transferrin\u2013adriamycin conjugates. Biochim Biophys Acta 23(1):84\u201388","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"9637_CR122","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1073\/pnas.78.7.4515","volume":"78","author":"R Sutherland","year":"1981","unstructured":"Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M (1981) Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci 78(7):4515\u20134519","journal-title":"Proc Natl Acad Sci"},{"key":"9637_CR123","author":"M Szwed","year":"2013","unstructured":"Szwed M, Matusiak A, Laroche-Clary A, Robert J, Marszalek I, Jozwiak Z (2013) Transferrin as a drug carrier: cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Toxicol Vitro. doi: 10.1016\/j.tiv.2013.09.013","journal-title":"Toxicol Vitro"},{"issue":"3","key":"9637_CR124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ijc.2910320314","volume":"32","author":"R Taetle","year":"1983","unstructured":"Taetle R, Honeysett JM, Trowbridge I (1983) Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells. Int J Cancer 32(3):343\u2013349","journal-title":"Int J Cancer"},{"issue":"4","key":"9637_CR125","first-page":"1759","volume":"46","author":"R Taetle","year":"1986","unstructured":"Taetle R, Castagnola J, Mendelsohn J (1986) Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res 46(4):1759\u20131763","journal-title":"Cancer Res"},{"issue":"3","key":"9637_CR126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1357-2725(02)00258-3","volume":"35","author":"D Trinder","year":"2003","unstructured":"Trinder D, Baker E (2003) Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35(3):292\u2013296","journal-title":"Int J Biochem Cell Biol"},{"issue":"5837","key":"9637_CR127","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/294171a0","volume":"294","author":"IS Trowbridge","year":"1981","unstructured":"Trowbridge IS, Domingo DL (1981) Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells. Nature 294(5837):171\u2013173","journal-title":"Nature"},{"issue":"4","key":"9637_CR128","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1073\/pnas.79.4.1175","volume":"79","author":"IS Trowbridge","year":"1982","unstructured":"Trowbridge IS, Lopez F (1982) Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci USA 79(4):1175\u20131179","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9637_CR129","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1073\/pnas.78.5.3039","volume":"78","author":"IS Trowbridge","year":"1981","unstructured":"Trowbridge IS, Omary MB (1981) Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci 78(5):3039\u20133043","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"9637_CR130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","volume":"71","author":"K Ulbrich","year":"2009","unstructured":"Ulbrich K, Hekmatara T, Herbert E, Kreuter J (2009) Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB). Eur J Pharma Biopharma 71(2):251\u2013256. doi: 10.1016\/j.ejpb.2008.08.021","journal-title":"Eur J Pharma Biopharma"},{"issue":"10","key":"9637_CR131","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","volume":"65","author":"R Meel van der","year":"2013","unstructured":"van der Meel R, Vehmeijer LJC, Kok RJ, Storm G, van Gaal EVB (2013) Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev 65(10):1284\u20131298. doi: 10.1016\/j.addr.2013.08.012","journal-title":"Adv Drug Deliv Rev"},{"issue":"2A","key":"9637_CR132","first-page":"799","volume":"20","author":"F Wang","year":"2000","unstructured":"Wang F, Jiang X, Yang DC, Elliott RL, Head JF (2000) Doxorubicin\u2013gallium\u2013transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7\/ADR cells. Anticancer Res 20(2A):799\u2013808","journal-title":"Anticancer Res"},{"issue":"21","key":"9637_CR133","doi-asserted-by":"crossref","first-page":"13235","DOI":"10.1016\/S0021-9258(18)90683-6","volume":"259","author":"JH Ward","year":"1984","unstructured":"Ward JH, Jordan I, Kushner JP, Kaplan J (1984) Heme regulation of HeLa cell transferrin receptor number. J Biol Chem 259(21):13235\u201313240","journal-title":"J Biol Chem"},{"issue":"1","key":"9637_CR134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1026246500788","volume":"65","author":"M Weaver","year":"2003","unstructured":"Weaver M, Laske DW (2003) Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) therapy of malignant gliomas. J Neurooncol 65(1):3\u201313","journal-title":"J Neurooncol"},{"issue":"10","key":"9637_CR135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nbt872","volume":"21","author":"GM Whitesides","year":"2003","unstructured":"Whitesides GM (2003) The \u2018right\u2019 size in nanobiotechnology. Nat Biotechnol 21(10):1161\u20131165","journal-title":"Nat Biotechnol"},{"issue":"3","key":"9637_CR136","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2249.1993.tb03434.x","volume":"92","author":"W Woith","year":"1993","unstructured":"Woith W, N\u00fcsslein I, Antoni C, Dejica DI, Winkler TH, Herrmann M, Pirner K, Kalden JR, Manger B (1993) A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro. Clin Exp Immunol 92(3):537\u2013542","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"9637_CR137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00710908","volume":"410","author":"F Wrba","year":"1986","unstructured":"Wrba F, Ritzinger E, Reiner A, Holzner JH (1986) Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study. Virchows Archiv A 410(1):69\u201373","journal-title":"Virchows Archiv A"},{"issue":"3","key":"9637_CR138","first-page":"350","volume":"10","author":"J Wu","year":"2007","unstructured":"Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee R (2007) Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharma Sci 10(3):350\u2013357","journal-title":"J Pharm Pharma Sci"},{"issue":"1\u20132","key":"9637_CR139","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2012.04.032","volume":"431","author":"L Wu","year":"2012","unstructured":"Wu L, Wu J, Zhou Y, Tang X, Du Y, Hu Y (2012) Enhanced antitumor efficacy of cisplatin by tirapazamine\u2013transferrin conjugate. Int J Pharm 431(1\u20132):190\u2013196. doi: 10.1016\/j.ijpharm.2012.04.032","journal-title":"Int J Pharm"},{"issue":"4","key":"9637_CR140","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bpj.2009.05.052","volume":"97","author":"V Yashunsky","year":"2009","unstructured":"Yashunsky V, Shimron S, Lirtsman V, Weiss A, Melamed Book N, Golosovsky M, Davidov D, Aroeti B (2009) Real-time monitoring of transferrin-induced endocytic vesicle formation by mid-infrared surface plasmon resonance. Biophys J 97(4):1003\u20131012","journal-title":"Biophys J"},{"issue":"4","key":"9637_CR141","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1423-0410.1984.tb00078.x","volume":"46","author":"CJ Yeh","year":"1984","unstructured":"Yeh CJ, Taylor CG, Faulk WP (1984) Transferrin binding by peripheral blood mononuclear cells in human lymphomas, myelomas and leukemias. Vox Sang 46(4):217\u2013223","journal-title":"Vox Sang"},{"issue":"3","key":"9637_CR142","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2008.10.006","volume":"133","author":"D Yoon","year":"2009","unstructured":"Yoon D, Chu DSH, Ng C, Pham E, Mason A, Hudson D, Smith V, MacGillivray RTA, Kamei D (2009) Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins. J Control Release 133(3):178\u2013184","journal-title":"J Control Release"},{"issue":"7","key":"9637_CR143","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/j.1460-2075.1986.tb04395.x","volume":"5","author":"M Zerial","year":"1986","unstructured":"Zerial M, Melancon P, Schneider C, Garoff H (1986) The transmembrane segment of the human transferrin receptor functions as a signal peptide. EMBO J 5(7):1543\u20131550","journal-title":"EMBO J"}],"container-title":["The Journal of Membrane Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00232-014-9637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00232-014-9637-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00232-014-9637-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T19:42:08Z","timestamp":1689018128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00232-014-9637-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9637"],"URL":"https:\/\/doi.org\/10.1007\/s00232-014-9637-0","relation":{},"ISSN":["0022-2631","1432-1424"],"issn-type":[{"value":"0022-2631","type":"print"},{"value":"1432-1424","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}